IP Library Granted Patent US 8,137,397
Granted Patent B2
US 8,137,397 · App. 10/787,618 · Granted Mar 20, 2012

Medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,397
App. No.
10/787,618
Granted
Mar 20, 2012
Kind
B2
Abstract

Medical devices, particularly stents, suitable for drug delivery and including a sugar, sugar derivative, inorganic ionic salt, polysaccharide, amino acid, amino acid derivative, polypeptide, surfactant, or combination thereof, are disclosed.

Claims (28)

1. A medical stent, comprising:

a generally tubular body;

a reservoir containing a first therapeutic agent; and

a body-fluid dissolvable protective layer disposed over the generally tubular body, the layer consisting essentially of an inorganic ionic salt selected from the group consisting of sodium chloride, potassium chloride, and sodium carbonate,

wherein

the layer covers the reservoir, and

the reservoir is formed of a bioerodible material.

2. The medical stent of claim 1 wherein the layer includes a second therapeutic agent.

3. The medical stent of claim 2 wherein the second therapeutic agent is different from the first therapeutic agent.

4. The medical stent of claim 1 wherein the reservoir is a layer of the first therapeutic agent.

5. The medical stent of claim 1 wherein the reservoir defines pores and the first therapeutic agent is disposed within the pores.

6. The medical stent of claim 1 wherein the reservoir comprises metal integral with the stent body.

7. The medical stent of claim 1 wherein the first therapeutic agent is selected from an group consisting of an antithrombogenic, antioxidant, anti-inflammatory, antiproliferative, or antibiotic.

8. The medical stent of claim 1 wherein the stent is a self-expanding stent.

9. The medical stent of claim 1 wherein the stent is a balloon-expandable stent.

10. The medical stent of claim 1 wherein the stent is a vascular stent.

11. The medical stent of claim 1 , wherein the layer consists of an inorganic ionic salt selected from the group consisting of sodium chloride, potassium chloride, and sodium carbonate.

12. The implantable medical device of claim 11 , wherein the bioerodible material comprises a bioerodible polymer.

13. The medical stent of claim 1 wherein the bioerodible material comprises a bioerodible polymer.

14. An implantable medical device, comprising:

an implantable body;

a reservoir containing a therapeutic agent; and

a body-fluid dissolvable protective layer disposed over the implantable body, the layer consisting essentially of an inorganic ionic salt selected from the group consisting of sodium chloride, potassium chloride, and sodium carbonate,

wherein

the layer covers the reservoir, and

the reservoir is formed of a bioerodible material.

15. The implantable medical device of claim 14 , wherein the implantable medical device is a balloon angioplasty catheter.

16. An implantable medical device, of claim 14 , wherein the bioerodible material comprises a bioerodible polymer.

Assignments (2)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2004
From: COLEN, FREDERICUS A.; KNAPP, DAVID
To: SCIMED LIFE SYSTEMS, INC.
Reel/Frame 015025/0120 →